跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MACRODANTIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MACRODANTIN
Authorized
STANDARD
MACRODANTIN
Alza Corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
62582394369fb345
Company
Alza Corporation
Type
Standard
Approval Details
Approval Id
62582394369fb345
Drug Approval Canada Name
MACRODANTIN
Product Name
MACRODANTIN
Status
Cancelled Post Market
Status Date
1999-08-06
Original Market Date
1993-12-31
Din
01997599
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:36.00
Atc Original
J01XE01 NITROFURANTOIN
Atc Name
j 01 xe 01
Aig Number
0101480005
Company Name
Alza Corporation
Company Address
1900 Charleston Road, Mountain View, California, United States, 94043-7210
Company Detail Path
/organization/alza-corporation
Company Information
Pharmaceutical Company Name
Alza Corporation
Country Name
United States
Province Name
California
City Name
vacaville,california,country_us
Address
700 Eubanks Dr
Active Ingredients
NITROFURANTOIN
25 MG / CAP
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
62582394369fb345
Type
Standard
Back to Health Canada Approvals